全文获取类型
收费全文 | 3719篇 |
免费 | 185篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 132篇 |
妇产科学 | 65篇 |
基础医学 | 596篇 |
口腔科学 | 114篇 |
临床医学 | 354篇 |
内科学 | 607篇 |
皮肤病学 | 136篇 |
神经病学 | 405篇 |
特种医学 | 154篇 |
外科学 | 578篇 |
综合类 | 17篇 |
一般理论 | 1篇 |
预防医学 | 117篇 |
眼科学 | 158篇 |
药学 | 214篇 |
中国医学 | 4篇 |
肿瘤学 | 241篇 |
出版年
2023年 | 16篇 |
2022年 | 45篇 |
2021年 | 85篇 |
2020年 | 61篇 |
2019年 | 76篇 |
2018年 | 93篇 |
2017年 | 60篇 |
2016年 | 71篇 |
2015年 | 97篇 |
2014年 | 114篇 |
2013年 | 167篇 |
2012年 | 217篇 |
2011年 | 237篇 |
2010年 | 163篇 |
2009年 | 126篇 |
2008年 | 201篇 |
2007年 | 220篇 |
2006年 | 193篇 |
2005年 | 178篇 |
2004年 | 171篇 |
2003年 | 151篇 |
2002年 | 131篇 |
2001年 | 83篇 |
2000年 | 69篇 |
1999年 | 78篇 |
1998年 | 32篇 |
1997年 | 39篇 |
1996年 | 31篇 |
1995年 | 31篇 |
1994年 | 19篇 |
1993年 | 20篇 |
1992年 | 39篇 |
1991年 | 25篇 |
1990年 | 48篇 |
1989年 | 31篇 |
1988年 | 28篇 |
1987年 | 26篇 |
1986年 | 30篇 |
1985年 | 30篇 |
1984年 | 21篇 |
1983年 | 15篇 |
1982年 | 15篇 |
1981年 | 18篇 |
1980年 | 17篇 |
1979年 | 21篇 |
1975年 | 18篇 |
1974年 | 13篇 |
1970年 | 14篇 |
1969年 | 23篇 |
1966年 | 13篇 |
排序方式: 共有3920条查询结果,搜索用时 46 毫秒
71.
Bradycardia and syncope as manifestations of partial epilepsy 总被引:5,自引:0,他引:5
L Constantin J B Martins R W Fincham R D Dagli 《Journal of the American College of Cardiology》1990,15(4):900-905
Although transient increases in heart rate typically occur, bradycardia has infrequently been noted in association with partial seizures. Five patients with temporal lobe epilepsy are described in whom sinus bradyarrhythmias and syncope were prominent manifestations of seizure activity. Partial improvement occurred in one of two patients in whom a permanent pacemaker was implanted before a diagnosis of epilepsy was established. Treatment with phenytoin or carbamazepine resulted in nearly complete resolution of symptoms in all five patients. Because pacemaker implantation does not prevent recurrent symptoms, but anticonvulsant therapy does, this experience underscores the importance of considering the diagnosis of partial epilepsy in selected patients with sinus bradyarrhythmias and syncope. 相似文献
72.
Janis E. Blair Ashwini Gotimukul Fangfang Wang Syeda A. Mina Helen C. Bartels Mark W. Burns Amy E. Kole Holenarasipur R. Vikram Juan C. Gea-Banacloche M. Teresa Seville Skye A. Buckner Petty Avinash Vikram Robert Orenstein 《Medicine》2021,100(24)
Most patients with coronavirus disease 2019 (COVID-19) have mild to moderate illness not requiring hospitalization. However, no study has detailed the evolution of symptoms in the first month of illness.At our institution, we conducted remote (telephone and video) visits for all adult outpatients diagnosed with COVID-19 within 24 h of a positive nasopharyngeal polymerase chain test for SARS-CoV-2. We repeated regular video visits at 7, 14, and 28 days after the positive test, retrospectively reviewed the prospective data collected in the remote visits, and constructed a week by week profile of clinical illness, through week 4 of illness.We reviewed the courses of 458 symptomatic patients diagnosed between March 12, 2020, and June 22, 2020, and characterized their weekly courses. Common initial symptoms included fever, headache, cough, and chest pain, which frequently persisted through week 3 or longer. Upper respiratory or gastrointestinal symptoms were much shorter lived, present primarily in week 1. Anosmia/ageusia peaked in weeks 2 to 3. Emergency department visits were frequent, with 128 visits in the 423 patients who were not hospitalized and 48 visits among the 35 outpatients (7.6%) who were eventually hospitalized (2 subsequently died). By the fourth week, 28.9% said their illness had completely resolved. After the 4-week follow up, 20 (4.7%) of the 423 nonhospitalized patients had further medical evaluation and management for subacute or chronic COVID-19 symptoms.Mild to moderate outpatient COVID-19 is a prolonged illness, with evolving symptoms commonly lasting into the fourth week of illness. 相似文献
73.
M G Kienzle J B Martins D J Wendt L Constantin R Hopson M L McCue 《The American journal of cardiology》1988,61(13):1012-1017
Sotalol is a nonselective beta-adrenergic blocking agent with Vaughn-Williams class III activity. Its efficacy was tested in 9 patients with sustained ventricular tachycardia (VT) that had previously remained inducible during electrophysiologic testing of type I drugs (procainamide or quinidine). Eight patients had coronary artery disease with remote myocardial infarction and 1 had cardiomyopathy (ejection fraction 0.34 +/- 0.08, mean +/- standard deviation). Type I drugs prolonged the effective refractory period of the right ventricle 12 +/- 14% and prolonged the VT cycle length 41 +/- 24%. In contrast, despite an equivalent effect on the effective refractory period, a sustained VT could no longer be initiated in any of the 8 patients ultimately tested while taking oral sotalol. Daily doses averaged 600 +/- 103 mg and blood levels associated with VT suppression in electrophysiologic studies were generally greater than 3,000 ng/ml. In addition, sotalol was moderately effective at reducing ventricular ectopic activity measured by ambulatory electrocardiography. Over a mean follow-up of 23 months (range 1 to 37), mild heart failure (3 patients), symptomatic brady-cardia requiring pacemaker (1) and drug-related polymorphous VT (1) have occurred. Sudden death occurred in 1 patient and nonfatal VT recurrence was noted in 2. Five of 8 chronically treated patients currently are successfully treated with minimal side effects. Sotalol appears to be a promising antiarrhythmic drug in the treatment of serious ventricular arrhythmias, even in patients refractory to type I antiarrhythmic agents. 相似文献
74.
Scridon Alina Dobreanu Dan Chevalier Philippe Şerban Răzvan Constantin 《Inflammation research》2015,64(6):383-393
Inflammation Research - Despite the long belief that the role of the adipose tissue was restricted to that of a passive store of triglycerides and a rich source of fatty acids, accumulating data... 相似文献
75.
76.
Virginie Pécourneau Yannick Degboé Thomas Barnetche Alain Cantagrel Arnaud Constantin Adeline Ruyssen-Witrand 《Archives of physical medicine and rehabilitation》2018,99(2):383-389.e1
Objective
To assess the effectiveness of exercise programs on disease activity and function in ankylosing spondylitis (AS) by a systematic review and meta-analysis of randomized controlled trials (RCTs).Data Sources
Medline via PubMed and Cochrane Library.Study Selection
Reports of RCTs examining the effectiveness of exercise programs for AS published up to May 2017.Data Extraction
Outcomes were evolution of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI) after the completion of exercise programs. Modalities of exercise were compared and the use of biologic therapy was reported.Data Synthesis
After screening 190 abstracts, we selected 26 reports for detailed evaluation and finally investigated 8 trials that assessed a home-based exercise program (2/8), swimming (1/8), Pilates training (1/8), or supervised exercises (4/8), for a total of 331 patients with AS. Four trials included patients receiving antitumor necrosis factor therapy. All trials except one showed a decrease in BASDAI and BASFI with exercise. The weighted mean difference was ?0.90 (95% confidence interval, ?1.52 to ?0.27; I2=69%; P=.005) for the BASDAI and ?0.72 (95% confidence interval, ?1.03 to ?0.40; I2=0%; P<.00001) for the BASFI in favor of exercise programs.Conclusions
Despite the small number of patients and the heterogeneity of exercise programs in the RCTs included in this meta-analysis, its results support the potential of exercise programs to improve disease activity and body function in AS. 相似文献77.
Matthieu Jabaudon Raiko Blondonnet Bruno Pereira Rodrigo Cartin-Ceba Christoph Lichtenstern Tommaso Mauri Rogier M. Determann Tomas Drabek Rolf D. Hubmayr Ognjen Gajic Florian Uhle Andrea Coppadoro Antonio Pesenti Marcus J. Schultz Marco V. Ranieri Helena Brodska Ségolène Mrozek Vincent Sapin Michael A. Matthay Jean-Michel Constantin Carolyn S. Calfee 《Intensive care medicine》2018,44(9):1388-1399
Purpose
The soluble receptor for advanced glycation end-products (sRAGE) is a marker of lung epithelial injury and alveolar fluid clearance (AFC), with promising values for assessing prognosis and lung injury severity in acute respiratory distress syndrome (ARDS). Because AFC is impaired in most patients with ARDS and is associated with higher mortality, we hypothesized that baseline plasma sRAGE would predict mortality, independently of two key mediators of ventilator-induced lung injury.Methods
We conducted a meta-analysis of individual data from 746 patients enrolled in eight prospective randomized and observational studies in which plasma sRAGE was measured in ARDS articles published through March 2016. The primary outcome was 90-day mortality. Using multivariate and mediation analyses, we tested the association between baseline plasma sRAGE and mortality, independently of driving pressure and tidal volume.Results
Higher baseline plasma sRAGE [odds ratio (OR) for each one-log increment, 1.18; 95% confidence interval (CI) 1.01–1.38; P?=?0.04], driving pressure (OR for each one-point increment, 1.04; 95% CI 1.02–1.07; P?=?0.002), and tidal volume (OR for each one-log increment, 1.98; 95% CI 1.07–3.64; P?=?0.03) were independently associated with higher 90-day mortality in multivariate analysis. Baseline plasma sRAGE mediated a small fraction of the effect of higher ΔP on mortality but not that of higher VT.Conclusions
Higher baseline plasma sRAGE was associated with higher 90-day mortality in patients with ARDS, independently of driving pressure and tidal volume, thus reinforcing the likely contribution of alveolar epithelial injury as an important prognostic factor in ARDS. Registration: PROSPERO (ID: CRD42018100241).78.
79.
Jordi Landier Guillaume Constantin de Magny Andres Garchitorena Jean-Fran?ois Guégan Jean Gaudart Laurent Marsollier Philippe Le Gall Tamara Giles-Vernick Sara Eyangoh Arnaud Fontanet Ga?tan Texier 《Emerging infectious diseases》2015,21(8):1414-1417
To determine when risk for Buruli ulcer is highest, we examined seasonal patterns in a highly disease-endemic area of Cameroon during 2002–2012. Cases peaked in March, suggesting that risk is highest during the high rainy season. During and after this season, populations should increase protective behaviors, and case detection efforts should be intensified. 相似文献
80.
Ultralow temperature cryoablation: Safety and efficacy of preclinical atrial and ventricular lesions
Felix Bourier MD Masateru Takigawa MD PhD Anna Lam MD Konstantinos Vlachos MD F. Daniel Ramirez MD MSc Claire A. Martin MD Antonio Frontera MD PhD Takeshi Kitamura MD Josselin Duchateau MD Thomas Pambrun MD Nicolas Derval MD Arnaud Denis MD Jerry Cox MD David Cabrita MD Alexander Babkin PhD Marion Constantin MA Pierre Jais MD Frédéric Sacher MD PhD Rémi Dubois MD PhD Oliver Bernus PhD Michel Haissaguerre MD Mélèze Hocini MD 《Journal of cardiovascular electrophysiology》2021,32(3):570-577